Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Bousso

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Nature Metabolism|April 11, 2024
A call for accessible tools to unlock single-cell immunometabolism researchJason Cosgrove, Antoine Marçais, Felix J Hartmann, et al.
Nature Methods|August 2, 2018
A human immune system mouse model with robust lymph node developmentYan Li, Guillemette Masse-Ranson, Zacarias Garcia, et al.
The Lancet. Rheumatology|March 29, 2025
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?Marc Scherlinger, Gaetane Nocturne, Marko Radic, et al.
Stem Cell Research & Therapy|May 1, 2026
CAR-T cells targeting fibroblast activation protein eliminate pathological fibroblasts and preserve cardiac function in a Duchenne Muscular Dystrophy murine modelCéline Marigny, Gaëlle Revet, Anne Berger, et al.
Plos One|July 29, 2014
Semaphorin 3F and neuropilin-2 control the migration of human T-cell precursorsDaniella Arêas Mendes-da-Cruz, Anne Colette Brignier, Vahid Asnafi, et al.
Science Immunology|February 25, 2022
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availabilityValeria Fumagalli, Valentina Venzin, Pietro Di Lucia, et al.
Immunity|October 23, 2021
Nitric oxide controls proliferation of Leishmania major by inhibiting the recruitment of permissive host cellsPauline Formaglio, Mohamad Alabdullah, Anastasios Siokis, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Nature Metabolism|April 11, 2024
A call for accessible tools to unlock single-cell immunometabolism researchJason Cosgrove, Antoine Marçais, Felix J Hartmann, et al.
Nature Methods|August 2, 2018
A human immune system mouse model with robust lymph node developmentYan Li, Guillemette Masse-Ranson, Zacarias Garcia, et al.
The Lancet. Rheumatology|March 29, 2025
CAR T-cell therapy in autoimmune diseases: where are we and where are we going?Marc Scherlinger, Gaetane Nocturne, Marko Radic, et al.
Stem Cell Research & Therapy|May 1, 2026
CAR-T cells targeting fibroblast activation protein eliminate pathological fibroblasts and preserve cardiac function in a Duchenne Muscular Dystrophy murine modelCéline Marigny, Gaëlle Revet, Anne Berger, et al.
Plos One|July 29, 2014
Semaphorin 3F and neuropilin-2 control the migration of human T-cell precursorsDaniella Arêas Mendes-da-Cruz, Anne Colette Brignier, Vahid Asnafi, et al.
Science Immunology|February 25, 2022
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availabilityValeria Fumagalli, Valentina Venzin, Pietro Di Lucia, et al.
Immunity|October 23, 2021
Nitric oxide controls proliferation of Leishmania major by inhibiting the recruitment of permissive host cellsPauline Formaglio, Mohamad Alabdullah, Anastasios Siokis, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Pageof 11